Literature DB >> 9286053

Protection, humoral and cell-mediated immune responses in calves immunized with multiple emulsion haemorrhagic septicaemia vaccine.

R Verma1, T N Jaiswal.   

Abstract

A multiple emulsion (ME), vaccine against Pasteurella multocida (P52) infection in cattle was prepared and the efficiency in terms of immunity to direct challenge, duration of this immunity for up to 1 year and the role of humoral and cell-mediated immune mechanisms were studied. ME vaccine was sterile, safe and was potent when tested in rabbits and calves. Nineteen calves were immunized with a single 4 ml dose of ME vaccine intramuscularly. Group of these calves were challenge infected with virulent P. multocida (P52) (10(-1) 18 h old broth culture) given by the subcutaneous route at 21 days, 3 months, 6 months, 9 months and 1 year. All the immunized calves withstood challenge infection and showed 100% protection. Humoral immune response was measured by indirect haemagglutination test (IHA) and enzyme-linked immunosorbant assay (ELISA). Statistically ELISA values were found to be superior to IHA values because of small coefficient of variance. A fall in mean antibody titres during 24 h, 48 h, post-challenge infection was recorded whereas a steady increase in the titre after 72 h up to 10 days was noticed. The prechallenge mean titre in animals correlated with survival of animals. Humoral antibodies were detected as early as 7 day post-immunization and persisted to 1 year after immunization. Leucocyte migration inhibition test showed > 20% migration inhibition during all pre- and post-challenge periods in animals suggesting an involvement of cell-mediated immune mechanism in protection. Our findings suggested that both humoral and cell-mediated immune responses contribute to protection in vaccinated animals. The results of these studies of ME vaccine showed that it can be successfully used for the effective control of haemorrhagic septicaemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9286053     DOI: 10.1016/s0264-410x(97)00025-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Safety and protective efficacy of intramuscular vaccination with a live aroA derivative of Pasteurella multocida B:2 against experimental hemorrhagic septicemia in calves.

Authors:  Mark P Dagleish; J Christopher Hodgson; Saeed Ataei; Anna Finucane; Jeanie Finlayson; Jill Sales; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

2.  Immune responses to haemorrhagic septicaemia (HS) vaccination in Trypanosoma evansi infected buffalo-calves.

Authors:  Lachhman D Singla; Prayag D Juyal; Narinder S Sharma
Journal:  Trop Anim Health Prod       Date:  2009-09-27       Impact factor: 1.559

3.  Protective immunity conferred by attenuated aroA derivatives of Pasteurella multocida B:2 strains in a mouse model of hemorrhagic septicemia.

Authors:  Mohammad Tabatabaei; Zhiqi Liu; Anna Finucane; Roger Parton; John Coote
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 4.  Spatial, Temporal, and Demographic Patterns in the Prevalence of Hemorrhagic Septicemia in 41 Countries in 2005-2019: A Systematic Analysis with Special Focus on the Potential Development of a New-Generation Vaccine.

Authors:  Reyad Almoheer; Mohd Effendy Abd Wahid; Hidayatul Aini Zakaria; Mohd Anuar Bin Jonet; Muhanna Mohammed Al-Shaibani; Adel Al-Gheethi; Siti Nor Khadijah Addis
Journal:  Vaccines (Basel)       Date:  2022-02-17

5.  Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpE.

Authors:  Tamás Hatfaludi; Keith Al-Hasani; Lan Gong; John D Boyce; Mark Ford; Ian W Wilkie; Noelene Quinsey; Michelle A Dunstone; David E Hoke; Ben Adler
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.